Show simple item record

dc.contributor.advisorCurrie, Margaret
dc.contributor.advisorDachs, Gabi
dc.contributor.advisorRobinson, Bridget
dc.contributor.advisorWillis, Jinny
dc.contributor.authorVolkova , Ekaterina
dc.date.available2011-11-24T23:12:49Z
dc.date.copyright2011
dc.identifier.citationVolkova , E. (2011). The link between obesity, colorectal cancer progression and tumour angiogenesis (Thesis, Doctor of Philosophy). University of Otago. Retrieved from http://hdl.handle.net/10523/2042en
dc.identifier.urihttp://hdl.handle.net/10523/2042
dc.description.abstractA link between obesity and risk of colorectal cancer development is strongly supported by epidemiological studies. Several obesity-related factors are implicated in this relationship. Among them, insulin resistance, a direct consequence of excess body weight, is considered as one of the most important. However, the role of obesity and related conditions in disease progression and outcome in colorectal cancer patients is not completely clear. This study investigated the contribution of obesity, insulin resistance and inflammation in colorectal cancer progression and patient survival. As a potential mechanism that could mediate the effect of obesity on colorectal cancer outcome, this study focused on tumour angiogenesis and on tumour resistance to chemotherapy. Patient body mass index (BMI), body surface area, as well as circulating markers of obesity, insulin resistance, inflammation (insulin, C-peptide, insulin-like growth factor-1 (IGF-1), C-reactive protein (CRP) and adiponectin) and angiogenesis (angiopoietin-2 (Ang-2), VEGF-A) were analysed in a New Zealand cohort of 344 colorectal cancer patients in relation to each other, to markers of disease progression and to patient survival. The effect of obesity-related and inflammatory factors on one of the main regulators of angiogenesis, hypoxia-inducible factor-1 (HIF-1), in colon cancer and stromal cells was analysed in vitro. Tumour angiogenesis was compared in two groups of colorectal cancer patients with distinct metabolic characteristics using immunohistochemical staining of tumour samples and analysis of angiogenic proteins levels. The effect of insulin and IGF-1 on cellular responses to chemotherapy drugs (5-fluorouracil, oxaliplatin and irinotecan) in colon cancer and endothelial cells was analysed in vitro. In the colorectal cancer patient cohort, serum CRP and Ang-2, but not other markers, were associated with more advanced tumour characteristics and with worse patient survival. The immunohistochemical analysis of tumour samples showed no difference in tumour angiogenesis between colorectal cancer patients with different metabolic profiles. However, the results suggested that obesity-related factors may contribute to regulation of angiogenic pathways, and this was confirmed in vitro and in tumour tissue protein extracts. Finally, insulin and IGF-1 were shown to modulate the in vitro cellular response to chemotherapy drugs in colon cancer and endothelial cells.
dc.format.mimetypeapplication/pdf
dc.language.isoen
dc.publisherUniversity of Otago
dc.rightsAll items in OUR Archive are provided for private study and research purposes and are protected by copyright with all rights reserved unless otherwise indicated.
dc.subjecttumour angiogenesis
dc.subjectcolorectal cancer
dc.subjectobesity
dc.titleThe link between obesity, colorectal cancer progression and tumour angiogenesis
dc.typeThesis
dc.date.updated2011-11-21T09:17:45Z
thesis.degree.disciplinePathology
thesis.degree.nameDoctor of Philosophy
thesis.degree.grantorUniversity of Otago
thesis.degree.levelDoctoral
otago.openaccessOpen
 Find in your library

Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record